US › Healthcare

Nuwellis Inc (NUWE)

US · Healthcare · Medical Devices

$4.58-1.72%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$2.0M

Revenue YoY

+14.1%

Net profit

$-4.8M

EPS

$-26.64

EPS estimate

$-23.80

Net margin

-245.2%

EPS came in at -26.64 against a street estimate of -23.80 — a miss of 11.9%.

Key statistics

Market cap

$1.9M

P/E

0.0

Forward P/E

0.0

P/B

0.18

Book value

$-32.20

EPS (TTM)

$3,923.28

52-week high

$172.89

52-week low

$0.32

50-day MA

$6.40

200-day MA

$229.06

Beta

0.02

Analyst view

with an average price target of $11.00.

Shareholding

Insiders

3.72%

Institutions

2.72%

Largest institutional holders

Fund	Stake
Sabby Management LLC	0.45%
UBS Group AG	0.12%
Tower Research Capital LLC	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
SBI Securities Co Ltd	0.00%
Ankerstar Wealth, LLC	0.00%
Geode Capital Management, LLC	0.00%
Caitong International Asset Management Co., Limited.	0.00%

Corporate actions

Action	Detail	Date
Split	1 : 9 effective Oct 27, 2026	2026-10-27

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Nuwellis Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.